Marshall Wace’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-755	Closed	-$125K	–	2953
2021 Q2	$125K	Sell	755 -3,066	-80%	-$508K	﹤0.01%	2000
2021 Q1	$737K	Buy	+3,821	New	+$737K	﹤0.01%	1510